Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak

Lancet

Volumn 361, Issue 9364, 2003, Pages 1168-1173

  Ewer, Katie ^a   Deeks, Jonathan ^b   Alvarez, Lydia ^a   Bryant, Gerry ^c   Waller, Sue ^c   Andersen, Peter ^d   Monk, Philip ^c   Lalvani, Ajit ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c Leicestershire Health Authority   (United Kingdom)

^d STATENS SERUM INSTITUT   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULIN;

ADOLESCENT; ARTICLE; BCG VACCINATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSPOT ASSAY; EPIDEMIC; EXPOSURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE; TUBERCULIN TEST; UNITED KINGDOM;

EID: 0037420497     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)12950-9     Document Type: Article

References (32)

1. Targeted tuberculin testing and treatment of latent tuberculosis infection: joint statement of the American Thoracic Society (ATS) and the Centers for Disease Control and Prevention (CDC). Am J Respir Crit Care Med 2000; 161: S221-47.
2. Huebner R.E., Schein M.F., Bass J.B. Jr. The tuberculin skin test. Clin Infect Dis. 17:1993;968-975.
3. Black G.F., Weir R.E., Floyd S., et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 359:2002;1393-1401.
4. Jasmer R.M., Nahid P., Hopewell P.C. Clinical practice: latent tuberculosis infection. N Engl J Med. 347:2002;1860-1866.
5. Zuber P.L., McKenna M.T., Binkin N.J., Onorato I.M., Castro K.G. Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA. 278:1997;304-307.
6. Rose A.M., Watson J.M., Graham C., et al. Tuberculosis at the end of the 20th century in England and Wales: results of a national survey in. Thorax ; 56. 2001:1998;173-179.
7. Taylor Z., O'Brien R.J. Tuberculosis elimination: are we willing to pay the price? Am J Respir Crit Care Med. 163:2001;1-2.
8. Mahairas G.G., Sabo P.J., Hickey M.J., Singh D.C., Stover C.K. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M bovis. J Bacteriol. 178:1996;1274-1282.
9. Harboe M., Oettinger T., Wiker H.G., Rosenkrands I., Andersen P. Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG. Infect Immun. 64:1996;16-22.
10. Andersen P., Munk M.E., Pollock J.M., Doherty T.M. Specific immune-based diagnosis of tuberculosis. Lancet. 356:2000;1099-1104.
11. Lein A.D., von Reyn C.F., Ravn P., Horsburgh C.R.J.R. Jr, Alexander L.N., Andersen P. Cellular immune responses to ESAT-6 discriminate between patients with pulmonary disease due to Mycobacterium avium complex and those with pulmonary disease due to Mycobacterium tuberculosis. Clin Diagn Lab Immunol. 6:1999;606-609.
12. Arend S.M., Andersen P., van Meijgaarden K.E., et al. Detection of active tuberculosis infection by T cell responses to early-secreted antigenic target 6-kDa protein and culture filtrate protein 10. J Infect Dis. 181:2000;1850-1854.
13. Lalvani A., Brookes R., Hambleton S., Britton W.J., Hill A.V., McMichael A.J. Rapid effector function in CD8+ memory T cells. J Exp Med. 186:1997;859-865.
14. Lalvani A., Pathan A.A., McShane H., et al. Rapid detection of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Am J Respir Crit Care Med. 163:2001;824-828.
15. Barnes P.F. Diagnosing latent tuberculosis infection: the 100-year upgrade. Am J Respir Crit Care Med. 163:2001;807-808.
16. Lalvani A., Pathan A.A., Durkan H., et al. Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cells. Lancet. 357:2001;2017-2021.
17. Lalvani A., Nagvenkar P., Udwadia Z., et al. Enumeration of T cells specific for RD1-encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis. 183:2001;469-477.
18. Chapman A.L., Munkanta M., Wilkinson K.A., et al. Rapid detection of active and latent tuberculosis infection in HIV-positive individuals by enumeration of Mycobacterium tuberculosis-specific T cells. AIDS. 16:2002;2285-2293.
19. Grzybowski S., Barnett G.D., Styblo K. Contacts of cases of active pulmonary tuberculosis. Bull Int Union Tuberc. 50:1975;90-106.
20. Stead W.W. Undetected tuberculosis in prison. Source of infection for community at large. JAMA. 240:1978;2544-2547.
21. Kenyon T.A., Valway S.E., Ihle W.W., Onorato I.M., Castro K.G. Transmission of multidrug-resistant Mycobacterium tuberculosis during a long airplane flight. N Engl J Med. 334:1996;933-938.
22. Houk V.N., Baker J.H., Sorensen K., Kent D.C. The epidemiology of tuberculosis infection in a closed environment. Arch Environ Health. 16:1968;26-35.
23. Houk V.H., Kent D.C., Baker J.H., Sorensen K., Hanzel G.D. The Byrd study: in-depth analysis of a micro-outbreak of tuberculosis in a closed environment. Arch Environ Health. 16:1968;4-6.
24. Control and prevention of tuberculosis in the United Kingdom: code of practice 2000. Thorax. 55:2000;887-901.
25. Immunisation against infectious disease. 1996;H M Stationery Office, London.
26. Carruthers K.J. Comparison of the Heaf (multiple puncture) and Mantoux tests using several tuberculins. Tubercle. 50:1969;22-41.
27. Deeks J.J. Systematic reviews of evaluations of diagnostic and screening tests. Egger M., Davey-Smith G., Altman D. Systematic reviews in health care: meta-analysis in context. 2001;BMJ Books, London.
28. Brock I., Munk M.E., Kok-Jensen A., Andersen P. Performance of whole blood IFN-gamma test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis. 5:2001;462-467.
29. Mazurek G.H., LoBue P.A., Daley C.L., et al. Comparison of a whole-blood interferon gamma assay with tuberculin skin testing for detecting latent Mycobacterium tuberculosis infection. JAMA. 286:2001;1740-1747.
30. Press releases. http://www.leics-ha.org.uk (accessed March 18, 2003).
31. Small P.M., Hopewell P.C., Singh S.P., et al. The epidemiology of tuberculosis in San Francisco: a population-based study using conventional and molecular methods. N Engl J Med. 330:1994;1703-1709.
32. Doherty T.M., Demissie A., Olobo J., et al. Immune responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 signal subclinical infection among contacts of tuberculosis patients. J Clin Microbiol. 40:2002;704-760.